Search
Search
In this series experts talk about their lab experiences with NGS technology for preimplantation genetic testing (PGT) and carrier screening microarray solutions. Dive into real-world case studies and testimonials that highlight the importance of cutting-edge technology in reproductive health.
In this talk, Dr. Ritu Garikipati explains why genetic screening and counseling are crucial for understanding underlying inherited diseases. Techniques like NGS and microarray help study and manage genetic disorders for healthier future generations.
Dr. Alpesh Patel discusses how advances in NGS and microarray technologies have significantly improved prenatal analysis, enabling early detection of genetic disorders. These innovations are crucial in addressing reproductive health issues stemming from lifestyle changes and delayed family planning.
NGS and microarray technology have revolutionized reproductive genetics by enabling the analysis of multiple genetic disorders simultaneously. Dr. Anuradha Udumudi talks about technologies that have significantly improved outcomes in areas such as infertility and preimplantation genetic analysis.
Advances in NGS and microarray technologies have significantly improved diagnostic yields in reproductive genetics, enabling better understanding of genetic abnormalities. Dr. Ventataswamy of Medgenome, Bengaluru, India, discusses microarray technology's ability to improve diagnostic yield by 15–20% compared to previous technologies like karyotyping and FISH.
Dr. Atul Thatai highlights NGS and microarrays as technologies of the future as these can offer more reliable and specific results compared to traditional biochemical tests. As these technologies become more affordable, they will likely replace older methods, allowing for earlier and more accurate understanding of genetic disorders.
Dr. Shankar discusses advancements in genetic analysis and counseling, particularly with NGS and microarray technologies. These improvements enhance understanding of genetic disorders, enable definitive diagnoses, clarify recurrence risks, and offer reproductive options, leading to development of targeted therapies. Lower analysis costs increase accessibility, further improving reproductive health outcomes.
In this video Dr. Ashwin Dalal talks about how high throughput technologies like NGS and microarrays have significantly increased the yield of genetic testing and diagnostics, aiding in identifying genetic causes of diseases and improving therapy management and prenatal diagnosis.
Dr Arvind Kumar talks about how advancements in genomic technologies, such as NGS and microarray, have significantly improved the early detection of prenatal diseases, shifting the focus from postnatal to prenatal analysis. Techniques like PGT are now used to to prioritize embryos to minimize the risk of genetic disorders before implantation.
Dr. Sachin Honguntikar addresses how breakthroughs in genetic analysis technologies such as microarray and NGS have significantly improved diagnostic efficiency and outcomes in reproductive health. However, there is a need to increase awareness and access to these technologies in Tier 2 and Tier 3 cities to ensure better health outcomes for all.
For Research Use Only. Not for use in diagnostic procedures.